Showing 1 - 6 results of 6 for search 'Ignacio Suárez Lozano', query time: 0.03s Refine Results
  1. 1
    Predictive factors of renal impairment in HIV-infected patients on antiretroviral therapy: Results from the VACH longitudinal cohort study

    Predictive factors of renal impairment in HIV-infected patients on antiretroviral therapy: Results from the VACH longitudinal cohort study by Pere Domingo, Ignacio Suarez-Lozano, Félix Gutierrez, Vicente Estrada, Hernando Knobel, Rosario Palacios, Antonio Antela, José-Ramón Blanco, Xavier Fulladosa

    Published 2019-09-01
    Get full text
    Article
  2. 2
    Predictive factors of renal impairment in HIV-infected patients on antiretroviral therapy: Results from the VACH longitudinal cohort study

    Predictive factors of renal impairment in HIV-infected patients on antiretroviral therapy: Results from the VACH longitudinal cohort study by Pere Domingo, Ignacio Suarez-Lozano, Félix Gutierrez, Vicente Estrada, Hernando Knobel, Rosario Palacios, Antonio Antela, José-Ramón Blanco, Xavier Fulladosa

    Published 2019-09-01
    Get full text
    Article
  3. 3
    Abacavir/Lamivudine plus Rilpivirine Is an Effective and Safe Strategy for HIV-1 Suppressed Patients: 48 Week Results of the SIMRIKI Retrospective Study.

    Abacavir/Lamivudine plus Rilpivirine Is an Effective and Safe Strategy for HIV-1 Suppressed Patients: 48 Week Results of the SIMRIKI Retrospective Study. by Jesús Troya, Pablo Ryan, Esteban Ribera, Daniel Podzamczer, Victor Hontañón, Jose Alberto Terrón, Vicente Boix, Santiago Moreno, Pilar Barrufet, Manuel Castaño, Ana Carrero, María José Galindo, Ignacio Suárez-Lozano, Hernando Knobel, Miguel Raffo, Javier Solís, María Yllescas, Herminia Esteban, Juan González-García, Juan Berenguer, Arkaitz Imaz, GESIDA-8314 Study Group

    Published 2016-01-01
    Get full text
    Article
  4. 4
    Correction: Abacavir/Lamivudine plus Rilpivirine Is an Effective and Safe Strategy for HIV-1 Suppressed Patients: 48 Week Results of the SIMRIKI Retrospective Study.

    Correction: Abacavir/Lamivudine plus Rilpivirine Is an Effective and Safe Strategy for HIV-1 Suppressed Patients: 48 Week Results of the SIMRIKI Retrospective Study. by Jesús Troya, Pablo Ryan, Esteban Ribera, Daniel Podzamczer, Victor Hontañón, Jose Alberto Terrón, Vicente Boix, Santiago Moreno, Pilar Barrufet, Manuel Castaño, Ana Carrero, María José Galindo, Ignacio Suárez-Lozano, Hernando Knobel, Miguel Raffo, Javier Solís, María Yllescas, Herminia Esteban, Juan González-García, Juan Berenguer, Arkaitz Imaz, GESIDA-8314 Study Group

    Published 2017-01-01
    Get full text
    Article
  5. 5
    Diagnóstico tardío de la infección por el virus de la inmunodeficiencia humana en la Cohorte VACH (1997-2002) Delayed diagnosis of HIV infection in the Spanish VACH cohort (1997-2002)

    Diagnóstico tardío de la infección por el virus de la inmunodeficiencia humana en la Cohorte VACH (1997-2002) Delayed diagnosis of HIV infection in the Spanish VACH cohort (1997-20... by Ramón Teira Cobo, Ignacio Suárez Lozano, Juan Miguel Santamaría Jáuregui, Alberto Terrón Pernía, Pere Domingo Pedrol, Juan González García, Jaime Cosín Ochaita, Esteban Ribera Pascuet, Trinitario Sánchez, Bernardino Roca Villanueva, Pompeyo Viciana Fernández, María Luisa García Alcalde, Paloma Geijo Martínez, Pepa Galindo Puerto, Antonio Vergara Campos, Fernando Lozano de León Naranjo, Agustín Muñoz Sánchez, Pablo Tebas

    Published 2007-02-01
    Get full text
    Article
  6. 6
    Risk factors and outcomes for late presentation for HIV-positive persons in Europe: results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE).

    Risk factors and outcomes for late presentation for HIV-positive persons in Europe: results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHER... by Amanda Mocroft, Jens D Lundgren, Miriam Lewis Sabin, Antonella d'Arminio Monforte, Norbert Brockmeyer, Jordi Casabona, Antonella Castagna, Dominique Costagliola, Francois Dabis, Stéphane De Wit, Gerd Fätkenheuer, Hansjakob Furrer, Anne M Johnson, Marios K Lazanas, Catherine Leport, Santiago Moreno, Niels Obel, Frank A Post, Joanne Reekie, Peter Reiss, Caroline Sabin, Adriane Skaletz-Rorowski, Ignacio Suarez-Lozano, Carlo Torti, Josiane Warszawski, Robert Zangerle, Céline Fabre-Colin, Jesper Kjaer, Genevieve Chene, Jesper Grarup, Ole Kirk, Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study in EuroCoord

    Published 2013-01-01
    Get full text
    Article

Search Tools: